T1	PROC 46 55	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	PROC 64 89	seguimiento a largo plazo
#2	AnnotatorNotes T2	C1517942; Long-term Follow-up; Health Care Activity
T3	ANAT 116 154	linfocitos T modificados genéticamente
#3	AnnotatorNotes T3	C4706671; Genetically modified T-cell; Cell
T4	PROC 254 263	protocolo
#4	AnnotatorNotes T4	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T5	PROC 103 111	tratados
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	ANAT 373 411	linfocitos T modificados genéticamente
#6	AnnotatorNotes T6	C4706671; Genetically modified T-cell; Cell
T7	PROC 459 468	protocolo
#7	AnnotatorNotes T7	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T8	DISO 576 604	mieloma múltiple recidivante
#8	AnnotatorNotes T8	C2349261; Relapse multiple myeloma; Neoplastic Process
T9	DISO 699 739	linfoma no Hodgkin de células B agresivo
T10	ANAT 721 730	células B
#9	AnnotatorNotes T10	C0004561; B-Lymphocytes; Cell
T11	ANAT 853 891	linfocitos T modificados genéticamente
#10	AnnotatorNotes T11	C4706671; Genetically modified T-cell; Cell
T12	PROC 194 203	protocolo
#11	AnnotatorNotes T12	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T13	PROC 1022 1033	seguimiento
#12	AnnotatorNotes T13	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T14	PROC 1047 1058	tratamiento
#13	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	PROC 1065 1074	protocolo
#14	AnnotatorNotes T15	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T16	PROC 1078 1089	tratamiento
#15	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 1270 1280	evaluación
#16	AnnotatorNotes T17	C1261322; Evaluation procedure; Health Care Activity
T18	PROC 1283 1296	procedimiento
#17	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T19	PROC 1438 1447	protocolo
#18	AnnotatorNotes T19	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T20	PROC 361 369	infusión
#19	AnnotatorNotes T20	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T21	PROC 621 632	tratamiento
#20	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	PROC 841 849	infusión
#21	AnnotatorNotes T22	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T23	Date 13 17	2017
T24	Date 76 89	a largo plazo
T25	LIVB 93 102	pacientes
#22	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	LIVB 299 328	sujetos adultos y pediátricos
#23	AnnotatorNotes T26	C0681850; Study Subject; Group + C0001675; Adult; Age Group + C0008059; Child; Age Group
T29	LIVB 493 502	pacientes
#24	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	Date 538 542	2017
T31	LIVB 554 571	pacientes adultos
#25	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T33	Date 661 665	2017
T34	LIVB 677 694	pacientes adultos
#26	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T37	LIVB 779 808	sujetos adultos y pediátricos
#27	AnnotatorNotes T37	C0681850; Study Subject; Group + C0001675; Adult; Age Group + C0008059; Child; Age Group
T40	LIVB 1125 1131	sujeto
#28	AnnotatorNotes T40	C0681850; Study Subject; Group
T41	LIVB 1138 1143	padre
#29	AnnotatorNotes T41	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T42	LIVB 1144 1149	madre
#30	AnnotatorNotes T42	C0026591; Mother (person); Family Group
T43	LIVB 1150 1169	representante legal
#31	AnnotatorNotes T43	C4288823; Legal Representative for the Study; Human
T45	LIVB 1332 1338	sujeto
#32	AnnotatorNotes T45	C0681850; Study Subject; Group
T27	PHYS 1193 1201	entender
#33	AnnotatorNotes T27	C0162340; Comprehension; Mental Process
T28	PROC 1395 1402	visitas
#34	AnnotatorNotes T28	C1512346; Patient Visit; Health Care Activity
A3	Population_data T26 Age
A4	Population_data T31 Age
A5	Population_data T34 Age
A6	Population_data T37 Age
A7	Status T20 History_of
A8	Status T22 History_of
A9	Status T13 History_of
A10	Status T14 History_of
A11	Status T16 History_of
#35	AnnotatorNotes T24	C0443252; Long-term; Temporal Concept
T32	Neg_cue 1475 1477	No
T35	Quantifier_or_Qualifier 1478 1488	applicable
A1	Assertion T35 Negated
R1	Negation Arg1:T32 Arg2:T35	
R2	Overlap Arg1:T2 Arg2:T24	
R3	Experiences Arg1:T25 Arg2:T5	
R4	Used_for Arg1:T3 Arg2:T5	
R5	Experiences Arg1:T26 Arg2:T20	
T36	Quantifier_or_Qualifier 348 360	al menos una
R6	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T36	
R7	Used_for Arg1:T6 Arg2:T20	
T38	PROC 418 425	estudio
A2	Status T38 History_of
#36	AnnotatorNotes T38	C0008976; Clinical Trials; Research Activity
R8	Experiences Arg1:T31 Arg2:T8	
T39	PROC 507 514	estudio
#37	AnnotatorNotes T39	C0008976; Clinical Trials; Research Activity
T44	Quantifier_or_Qualifier 607 632	resistente al tratamiento
#38	AnnotatorNotes T44	C0205269; Unresponsive to Treatment; Functional Concept
R9	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T44	
R10	Experiences Arg1:T31 Arg2:T21	
R11	Experiences Arg1:T34 Arg2:T9	
R12	Location_of Arg1:T10 Arg2:T9	
#39	AnnotatorNotes T9	C5555120; Aggressive B-Cell Non-Hodgkin Lymphoma; Neoplastic Process
R13	Experiences Arg1:T34 Arg2:T8	
R14	Experiences Arg1:T34 Arg2:T21	
R15	Experiences Arg1:T29 Arg2:T8	
R16	Experiences Arg1:T29 Arg2:T9	
R17	Experiences Arg1:T37 Arg2:T22	
R18	Used_for Arg1:T11 Arg2:T22	
T46	Quantifier_or_Qualifier 828 840	al menos una
R19	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T46	
T47	PROC 903 910	estudio
A12	Status T47 History_of
#40	AnnotatorNotes T47	C0008976; Clinical Trials; Research Activity
T48	Quantifier_or_Qualifier 982 994	interrumpido
#41	AnnotatorNotes T48	C0443239; Interrupted; Qualitative Concept
R20	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T48	
T49	Quantifier_or_Qualifier 997 1007	finalizado
#42	AnnotatorNotes T49	C1272693; Ended - status; Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T49	
R22	After Arg1:T13 Arg2:T14	
R23	Experiences Arg1:T37 Arg2:T14	
R24	Experiences Arg1:T37 Arg2:T16	
R25	Experiences Arg1:T40 Arg2:T27	
R26	Experiences Arg1:T41 Arg2:T27	
R27	Experiences Arg1:T42 Arg2:T27	
R28	Experiences Arg1:T43 Arg2:T27	
T50	CONC 1234 1237	DAI
#43	AnnotatorNotes T50	C5446092; Informed Assent for Research; Intellectual Product ['Documento de Asentimiento Informado' ?] 
T51	CONC 1230 1233	DCI
#44	AnnotatorNotes T51	C0009797; Consent Forms; Intellectual Product
T52	Observation 1205 1237	irmar voluntariamente un DCI/DAI
#45	AnnotatorNotes T52	C0742766; consent signed; Finding (?)
R29	Before Arg1:T52 Arg2:T17	
R30	Before Arg1:T52 Arg2:T18	
R33	Overlap Arg1:T27 Arg2:T52	
R36	Experiences Arg1:T40 Arg2:T17	
R37	Experiences Arg1:T40 Arg2:T18	
T53	Observation 1344 1447	poder y estar dispuesto a cumplir el calendario de visitas del estudio y otros requisitos del protocolo
R39	Experiences Arg1:T29 Arg2:T21	
#46	AnnotatorNotes T35	C1706839; Applicable; Qualitative Concept
A13	Experiencer T25 Patient
A14	Experiencer T26 Patient
A15	Experiencer T29 Patient
A16	Experiencer T31 Patient
A17	Experiencer T34 Patient
A18	Experiencer T37 Patient
A19	Experiencer T40 Patient
A20	Experiencer T41 Family_member
A21	Experiencer T42 Family_member
A22	Experiencer T43 Other
A23	Experiencer T45 Patient
